Innovative New COPD Maintenance Treatment Now Available Through DirectRx Specialty Pharmacy
August 28 2024 - 11:51AM
DirectRx, a leading national specialty pharmacy dedicated to
serving individual patients with complex and chronic health needs,
today announced that is has been selected to be part of the
exclusive distribution network for the newest and first-in-class
COPD medication, Ohtuvayre by Verona Pharma. The announcement was
made by Alban Ivezaj, President of DirectRx.
“We followed the clinical trials closely which found that
Ohtuvayre demonstrated both early and sustained improvements in
lung function across a broad population of patients with COPD,”
said Amanda Berishaj, DirectRx VP of Clinical Services. “With our
expertise in COPD, we are excited to be partnering with Verona
Pharma on the launch on their novel and innovative therapy.”
Ohtuvayre was approved by the FDA on June 26 and is now
available for the maintenance treatment of chronic obstructive
pulmonary disease (COPD) in adult patients. The new treatment is
simple and effective, combining a bronchodilator and non-steroidal
anti-inflammatory effects in one molecule. The treatment is
delivered directly to the lungs through a standard jet nebulizer
without the need for any complex hand-breath coordination.
As a broad label therapy, Ohtuvayre can be prescribed as a
monotherapy or as an add-on medication with current therapies for
COPD. Ohtuvayre is Verona Pharma’s brand name for ensifentrine, a
selective dual inhibitor of PDE3/4.
“We are honored to be selected as part of Ohtuvayre’s exclusive
distribution network of accredited pharmacy partners,” said Ivezaj.
“Thousands of prescribers across the United States trust DirectRx
with their patients’ COPD medications – we are excited to be able
to support these prescriber partners with Ohtuvayre.”
DirectRx, an independent
specialty pharmacy with dual accreditation from both ACHC and URAC,
provides patients with unparalleled, personalized pharmaceutical
care. The company continues to invest in technology and people to
provide unparalleled service to patients and doctors in all 50
states. www.DirectRx.com
CONTACT: Marina Lekocaj,
DirectRx (248) 273-0489